Alemtuzumab/busulfan/fludarabineVarious toxicities: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1832卷 / 1期

关键词：

D O I：

10.1007/s40278-020-86556-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：23 / 23

相关论文

共 50 条

[1] Busulfan/cyclophosphamide/fludarabineVarious toxicities: 4 case reports
Reactions Weekly, 2022, 1905 (1) : 138 - 138
[2] Antithymocyte globulin/busulfan/fludarabineVarious toxicities: 5 case reports
Reactions Weekly, 2017, 1678 (1) : 27 - 27
[3] Antithymocyte globulin/cyclophosphamide/fludarabineVarious toxicities: 4 case reports
Reactions Weekly, 2021, 1842 (1) : 55 - 55
[4] Cyclophosphamide/fludarabineVarious toxicities: 10 case reports
Reactions Weekly, 2020, 1801 (1) : 98 - 98
[5] Cyclophosphamide/fludarabineVarious toxicities: 8 case reports
Reactions Weekly, 2015, 1533 (1) : 146 - 146
[6] Cyclophosphamide/fludarabineVarious toxicities: 3 case reports
Reactions Weekly, 2015, 1571 (1) : 68 - 68
[7] Cyclophosphamide/fludarabineVarious toxicities: 5 case reports
Reactions Weekly, 2021, 1872 (1) : 156 - 156
[8] Alemtuzumab/busulfan/fludarabineSarcoidosis (first report with alemtuzumab and busulfan): 2 case reports
Reactions Weekly, 2007, 1156 (1) : 6 - 6
[9] Bortezomib/cytarabine/fludarabineVarious toxicities: 13 case reports
Reactions Weekly, 2021, 1856 (1) : 112 - 112
[10] Busulfan/melphalan/thiotepaVarious toxicities: 4 case reports
Reactions Weekly, 2017, 1656 (1) : 115 - 115

← 1 2 3 4 5 →